Over the past five years, developmental funds have been used in three categories, support of pilotprojects, recruitment of new investigators, and development of new shared resources. Major prioritieshave been the expansion of population research, and the stimulation and promotion of translationalresearch. Support for 13 new investigators contributed to enhanced research activities in Programs 1, 2,4, 5, and 6. Six of the faculty recruited between 2002 and early 2005 have now received peer-reviewedfunding, and all 12 (one faculty deceased) are active UCCRC members. Examples of significantrecruitments of the past grant cycle are: Habibul Ahsan, MD, a molecular epidemiology who assumed therole of Associate Director for Population Research; Nathan Ellis, PhD, and Mark Lingen, DOS, PhD. Sixnew core facilities were supported with CCSG developmental funds: Optical Imaging (animal), BiomedicalInformatics, Tissue Procurement, Proteomics, Image Response Assessment, and cGMP. TissueProcurement is now a fully-developed component of the Human Tissue Resource Center. The developingcores continue to grow and have significantly contributed to interdisciplinary collaborations andtranslational research.Over the next grant period, we are requesting $500,000/year for: (1) recruitment of new investigators($200K); (2) program development/Program Pilot Projects ($150K); and (3) development of new corefacilities ($150K). Population research development, through both recruitment and support of pilotprojects will continue to be the highest priority. Dr. Habib Ahsan will lead these recruitment efforts and, inthe next 5 years, we expect to add 3-4 new faculty in the areas of molecular cancer epidemiology,environmental cancer epidemiology, behavioral psychology, and chemoprevention trials research.Expansion of translational research will continue as a major goal, and will be supported through bothtargeted recruitments and pilot project funding. Recruitment developmental funds will also be used tosupport the growing program in Pediatric Hematology/Oncology. We plan to continue to support theOptical Imaging, Biomedical Informatics, Image Response Assessment, and cGMP developing cores, aswell as two new shared facilities: Drug Discovery and Development and the Cellular Screening Center,and a planned Epidemiology and Recruitment Core. It is anticipated that as the need for other newtechnologies is identified, CCSG developmental funds will be applied to their development.
Showing the most recent 10 out of 668 publications
